GLP-1 drugs may reach fewer than one in 10 people who need them, experts predict
The World Health Organization (WHO) has announced its official guidance on the use of GLP-1 drugs for treating obesity.GLP-1 drugs are medications that mimic the natural hormone glucagon-like peptide-1 (GLP-1), which are most commonly used for type 2 diabetes and medical weight loss.The first guideline, released on Dec. 1, aims to address the "growing global health challenge of obesity," WHO wrote in a press release.WEIGHT LOSS DRUGS COULD ADD YEARS […]